|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2019
|
1. |
Holmøy, Trygve; Fevang, Børre; Olsen, David Benee; Spigset, Olav; Bø, Lars. Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes 2019 ;Volum 12.(1) s. 1-5 UiO AHUS OUS NTNU STO UiB HAUKELAND
Untitled
|
|
2. |
Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve. B cell depletion in the treatment of multiple sclerosis. Expert Opinion on Biological Therapy 2019 ;Volum 19.(3) s. 261-271 UiB HAUKELAND UiO OUS AHUS
Untitled
|
|
3. |
Nystad, Agnes Elisabeth; Lereim, Ragnhild Reehorst; Wergeland, Stig; Oveland, Eystein; Myhr, Kjell-Morten; Bø, Lars; Torkildsen, Øivind. Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. Journal of Neuroimmunology 2019 ;Volum 339. HAUKELAND UiB
Untitled
|
|
4. |
Stokke, Silje Agnethe; Lehmann, Anne Kristine; Trovik, Linn; Kristoffersen, Einar Klæboe; Bø, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind. Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Multiple Sclerosis 2019 s. 1-9 UiB HAUKELAND
Untitled
|
|